您的位置: 首页 > 农业专利 > 详情页

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
专利权人:
Bayer HealthCare LLC
发明人:
Wang, Zhuozhi,Pan, Junliang,Grudzinska, Joanna,Votsmeier, Christian,Tebbe, Jan,Birkenfeld, Joerg,Wobst, Nina,Bruckner, Simone,Stenig, Susanne
申请号:
AU2016269554
公开号:
AU2016269554B2
申请日:
2016.12.09
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2016269554B220181220.pdf#####Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) Abstract Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. H: fmt Interwoven NRPortbl DCC FMT 123336731 .docx - 9/12/16
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充